About-us technologies products Clinical-trials collaborations news careers contact-us
About Philogen

Philogen is a Swiss-Italian integrated biotechnology company founded in 1996, with the mission to develop innovative biopharmaceuticals for the treatment of angiogenesis-related disorders.....>>

About Philochem

Philochem is a fully owned daughter company of Philogen and represents the Discovery Unit of the Philogen group.

Philochem is based in Otelfingen (Zurich, Switzerland).>>

Recent News

Siena (Italy),
September 15st, 2014

Philogen reports significant preclinical data for targeted
cytotoxics, a novel class of pharmaceutical products with
improved therapeutic performance.
Please see Press Release for more information.

Upcoming Events

Geneva (Switzerland),
November 10th-14th, 2014

Dario Neri will present 'Immunocytokines: clinical development and efficacy findings' at European Antibody Congress